• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The journal of sexual medicine >Vulvar and vaginal atrophy in postmenopausal women: Findings from the REVIVE (REal women's VIews of treatment options for menopausal vaginal changEs) survey
【24h】

Vulvar and vaginal atrophy in postmenopausal women: Findings from the REVIVE (REal women's VIews of treatment options for menopausal vaginal changEs) survey

机译：绝经后妇女的外阴和阴道萎缩：REVIVE（REal女性对绝经后阴道改变的治疗选择的观点）调查结果

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Introduction: Vulvar and vaginal atrophy (VVA) is a chronic medical condition experienced by many postmenopausal women. Symptoms include dyspareunia (pain with intercourse), vaginal dryness, and irritation and may affect sexual activities, relationships, and activities of daily life. Aim: The aim of this study is to characterize postmenopausal women's experience with and perception of VVA symptoms, interactions with healthcare professionals (HCPs), and available treatment options. Methods: An online survey was conducted in the United States in women from KnowledgePanel?, a 56,000-member probability-selected Internet panel projectable to the overall US population. Altogether, 3,046 postmenopausal women with VVA symptoms (the largest US cohort of recent surveys) responded to questions about their knowledge of VVA, impact of symptoms on their activities, communication with HCPs, and use of available treatments. Main Outcome Measures: Percent is calculated as the ratio of response over total responding for each question for all and stratified participants. Results: The most common VVA symptoms were dryness (55% of participants), dyspareunia (44%), and irritation (37%). VVA symptoms affected enjoyment of sex in 59% of participants. Additionally, interference with sleep, general enjoyment of life, and temperament were reported by 24%, 23%, and 23% of participants, respectively. Few women attributed symptoms to menopause (24%) or hormonal changes (12%). Of all participants, 56% had ever discussed VVA symptoms with an HCP and 40% currently used VVA-specific topical treatments (vaginal over-the-counter [OTC] products [29%] and vaginal prescription therapies [11%]). Of those who had discussed symptoms with an HCP, 62% used OTC products. Insufficient symptom relief and inconvenience were cited as major limitations of OTC products and concerns about side effects and cancer risk limited use of topical vaginal prescription therapies. Conclusions: VVA symptoms are common in postmenopausal women. Significant barriers to treatment include lack of knowledge about VVA, reluctance to discuss symptoms with HCPs, safety concerns, inconvenience, and inadequate symptom relief from available treatments.
机译：简介：外阴和阴道萎缩（VVA）是许多绝经后女性所经历的慢性疾病。症状包括性交困难（性交疼痛），阴道干燥和刺激感，并可能影响性活动，性关系和日常生活活动。目的：本研究的目的是描述绝经后妇女对VVA症状的体验和感知，与医护人员（HCP）的相互作用以及可用的治疗选择。方法：在美国对KnowledgePanel？中的女性进行了一项在线调查，该调查是一个由56,000名成员组成的概率选择互联网小组，预计可覆盖整个美国人口。共有3,046名具有VVA症状的绝经后妇女（美国近期调查中最大的队列）回答了有关其VVA知识，症状对其活动的影响，与HCP的交流以及使用现有治疗方法的问题。主要结果衡量标准：百分比是根据所有参与者和分层参与者对每个问题的回答与总回答的比率来计算的。结果：最常见的VVA症状是干燥（占参与者的55％），性交困难（44％）和刺激（37％）。 VVA症状影响了59％的参与者的性乐趣。此外，分别有24％，23％和23％的参与者报告了干扰睡眠，一般的生活享受和性情。很少有妇女将症状归因于更年期（24％）或荷尔蒙变化（12％）。在所有参与者中，有56％曾与HCP讨论过VVA症状，目前有40％曾使用过VVA特异的局部治疗（阴道非处方[OTC]产品[29％]和阴道处方疗法[11％]）。在与HCP讨论过症状的患者中，有62％使用了OTC产品。症状缓解和不便被认为是OTC产品的主要局限性，并且对副作用和癌症风险的担忧限制了局部阴道处方疗法的使用。结论：绝经后女性中常见VVA症状。治疗的主要障碍包括对VVA的了解不足，不愿意与HCP讨论症状，安全性问题，不便之处以及可用治疗方法不能充分缓解症状。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号